Abbott Coronary Microvascular Dysfunction Algorithm

Logo

Ibaṣepọ Catheter

(c)

  • Fọ daradara 1
  • Ibaṣepọ itọsọna Coaxial 1
  • Rii daju pe ko si damping1
    Ibaṣepọ Catheter

(A)

Waya ilosiwaju

  • Beere LAD ayafi ti agbegbe kan ti iwulo ba wa 2
  • Sensọ waya iwaju 2/3 distally ninu ọkọ 3
  •  Abojuto GTN/NTG1
    Waya ilosiwaju

(T)

Akoko irekọja ni Isinmi

  • Fọ/sọ isinmi-tẹlẹ Tmn lati ko ẹjẹ eyikeyi kuro ati iyatọ 3
  • Iyọ otutu yara 3
  • Brisk 3 milimita x 3 awọn abẹrẹ 3
  • Adirẹsi ita (± 0.25s) ṣaaju ki o to tẹsiwaju 4*
    * Tun wiwọn Tmn isinmi
    Akoko irekọja ni Isinmi

(H)

Hyperemic Transit Time

  • Fa hyperemia 5
  • Jẹrisi hyperemia*6
  • Flush/sọ iṣaju Tmn hyp lati ko ẹjẹ eyikeyi kuro ati iyatọ 6
  • Iyọ otutu yara 6
  • Brisk 3 milimita x 3 awọn abẹrẹ 6
  • Adirẹsi awọn ita (± 0.15s) ṣaaju ki o to tẹsiwaju 4 **
    * Dinku ninu titẹ, awọn ami aisan alaisan, FFR ju *
    * Tun wiwọn Tmn hyp

Hyperemic Transit Time

(C)

Ifipamọ Sisan Apọnilọrun (CFR)

  • CFR <2.5*4
  • Agbegbe grẹy CFR 2.0-2.4*
    * Idagbasoke ipohunpo
    Ifipamọ Sisan Apọnilọrun (CFR)

(M)

Atọka ti Microcirculatory Resistance (IMR)

  • IMR ≥252
  • Lo IMRcorr ti o ba jẹ FFR ≤0.807
    Atọka ti Microcirculatory Resistance (IMR)

(D)

Aisan ayẹwo

  • Ayẹwo ti CMD ti o da lori IMR ≥25 ati CFR <2.5 * 2,4
  • Agbegbe grẹy CFR 2.0-2.4*
  • Tọkasi awọn itọnisọna ati iwe adehun ifọkanbalẹ2,4, 8-9
    * Idagbasoke ipohunpo
    Aisan ayẹwo

GTN (glyceryl trinitrate) |
NTG (nitroglycerin) |
LAD (osi iwaju sokale) |
FFR (ida sisan ipamọ) |
IMRcorr (IMR atunse) |
CMD (coronary microvascular alailoye) |
Tmnisimi (isinmi irekọja tumo si akoko) |
Tmnhyp (akoko irekọja hyperemic)

Awọn itọkasi: 

  1. Berry C. Ifipamọ Sisan Ida, Ifipamọ Sisan Coronary ati Atọka ti Resistance Microvascular ni Iṣe iṣegun. Radcliffe Ẹkọ ọkan. Ọdun 2014, 1-6.
  2. Kunadian V, et al. Iwe Ifọwọsowọpọ Amoye EAPCI lori Ischaemia pẹlu Awọn iṣọn-alọ ọkan ti kii ṣe Idilọwọ. EHJ. 2020; 0, 1-21.
  3. Fearon W, et al. Igbelewọn Apaniyan ti Microvasculature Coronary: Atọka ti Resistance Microcirculatory. Circ Cardiovasc Interv. Ọdun 2017; 10:e005361
  4. Perera D, et al. Fisioloji iṣọn-alọ ọkan invasive ni awọn alaisan ti o ni angina ati arun iṣọn-alọ ọkan ti ko ni idiwọ. Okan. 2022; 0, 1-8.
  5. Ford T, et al. Iṣoogun Iṣoogun Stratified Lilo Idanwo Iṣẹ Iṣe Apọnirun Invasive ni Angina: Idanwo CorMicA. JACC. Ọdun 2018, 72, 2841-55.
  6. Ang D, et al. Ilana Iwadii Awujọ Interventional: Itọsọna Wulo fun Iṣiroye Iṣẹ Iṣẹ Vascular Coronary. JOVE 2022; 181, e2265.
  7. Yong A, et al. Iṣiro Atọka ti Resistance Microcirculatory Laisi Iwọn Iwọn Iwọn Awọ Apọpọ ni Iwaju ti Epicardial Stenosis. JACC: Cardiovasc Interv. Ọdun 2013; 6, 53-8.
  8. Knuuti J, et al. Awọn itọnisọna ESC. EHJ. 2020; 41, 407-477.
  9. Gulati M, et al. 2021 Ìrora Àyà Itọsọna, Circulation. Ọdun 2021; 144, e368-e454.

Awọn apejuwe jẹ awọn aṣoju olorin nikan ati pe ko yẹ ki o gba bi awọn iyaworan ẹrọ tabi awọn aworan.

Alaye ti o wa ninu rẹ fun PIPIN ni ita AMẸRIKA NIKAN. Ṣayẹwo ipo ilana ẹrọ ni awọn agbegbe nibiti isamisi CE kii ṣe ilana ni agbara.
Abbott International BVBA

Park Lane, Culliganlaan 2B, 1831 Diegem, Belgium, Tẹli: 32.2.714.14.11  www.cardiovascular.abbott ©2023 Abbott. Gbogbo awọn ẹtọ wa ni ipamọ. MAT-2114614 v3.0

Logo

 

Awọn iwe aṣẹ / Awọn orisun

Abbott Coronary Microvascular Dysfunction Algorithm [pdf] Itọsọna olumulo
Algorithm Alaiṣan ẹjẹ iṣọn-alọ ọkan, alugoridimu alailoye microvascular, Algorithm alaiṣe, alugoridimu
Abbott Coronary Microvascular Dysfunction Algorithm [pdf] Ilana itọnisọna
Algorithm Alaiṣan ẹjẹ iṣọn-alọ ọkan, alugoridimu alailoye microvascular, Algorithm alaiṣe, alugoridimu

Awọn itọkasi

Fi ọrọìwòye

Adirẹsi imeeli rẹ kii yoo ṣe atẹjade. Awọn aaye ti a beere ti wa ni samisi *